EUVIMEDEUVIMED entdecken
Crossref

Neoadjuvant chemoimmunotherapy for locally advanced oral cavity cancer: a narrative review

Micah K. Harris, Joshua D. Smith, Kevin J. Contrera, Steven B. Chinn, Dan P. Zandberg, Matthew E. Spector

Academia Oncology · 05.06.2026 · 3 (2)

DOI: 10.20935/acadonco8340 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Academia Oncology, online erschienen am 05.06.2026. Verfasst von Micah K. Harris und 5 weiteren Autor:innen. Die Arbeit nennt 54 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Locally advanced oral cavity squamous cell carcinoma (OCSCC) presents a significant challenge, with survival rates remaining poor despite advances in surgical technique and chemoradiation. While induction chemotherapy has historically failed to demonstrate a clear survival benefit, the emergence of neoadjuvant immunotherapy and chemoimmunotherapy has opened new avenues for investigation. There is now a rapidly growing focus on the potential for neoadjuvant chemoimmunotherapy to improve survival for locally advanced OCSCC. Moreover, neoadjuvant chemoimmunotherapy holds the potential to reduce preoperative tumor burden, potentially allowing for a response-adapted surgery that optimizes postoperative quality of life while maintaining oncologic safety. Despite these promising early findings, data are heterogeneous and randomized controlled trials are lacking. This narrative review provides an overview and interpretation of current data as it relates to the role of neoadjuvant chemotherapy and immunotherapy to improve survival and postoperative function for locally advanced OCSCC, highlighting the need for standardized protocols and additional trials.

Zitieren

APA

Harris, M. K., Smith, J. D., Contrera, K. J., Chinn, S. B., Zandberg, D. P., & Spector, M. E. (2026). Neoadjuvant chemoimmunotherapy for locally advanced oral cavity cancer: a narrative review. Academia Oncology, 3(2). https://doi.org/10.20935/acadonco8340

Vancouver

Harris MK, Smith JD, Contrera KJ, Chinn SB, Zandberg DP, Spector ME. Neoadjuvant chemoimmunotherapy for locally advanced oral cavity cancer: a narrative review. Academia Oncology. 2026;3(2). doi:10.20935/acadonco8340

BibTeX
@article{Harris2026,
  author = {Harris, Micah K. and Smith, Joshua D. and Contrera, Kevin J. and Chinn, Steven B. and Zandberg, Dan P. and Spector, Matthew E.},
  title = {Neoadjuvant chemoimmunotherapy for locally advanced oral cavity cancer: a narrative review},
  journal = {Academia Oncology},
  year = {2026},
  volume = {3},
  number = {2},
  doi = {10.20935/acadonco8340}
}
Kostenlos starten →